(Hypertension. 1999;33:933-936.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Graduate School of Human and Environmental Studies, University of Kyoto (N.K., Y.Y.); The Institute for Adult Diseases Asahi Life Foundation, Tokyo (T.S.); the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo (H.M., H.K., Y.Y.); and the Department of Laboratory Medicine, Shimane Medical University (T.N.).
Correspondence to Norihiro Kato, MD, PhD, Graduate School of Human and Environmental Studies, University of Kyoto, Yoshida Nihonmatsu-cho Sakyo-ku, Kyoto 606, Japan. E-mail kato{at}helios.jinkan.kyoto-u.ac.jp
AbstractSignificant association
between a Glu298Asp polymorphism of the endothelial
nitric oxide synthase (eNOS) gene and essential
hypertension was recently reported in Japanese populations, with the
298Asp variant showing a higher prevalence in hypertensive patients
(10.3% to 12.0%) than in normotensive subjects (5.0% to 5.8%). In
contrast, another study demonstrated that the 298Glu variant was
significantly associated with hypertension in a Caucasian population.
We therefore undertook an extensive association study in Japanese to
resolve these contradictory claims. A total of 1165 individuals were
selected from clinic outpatients and hospital staff in a single
institution. The relevance of the Glu298Asp polymorphism to
hypertension in this population was tested in 2 ways. First, a
case-control study was conducted in 549 hypertensive and 513
normotensive subjects within the study population, with the
2 statistic used to test the significance of an
association between eNOS genotype and the
presence of hypertension. Second, an ANOVA was used to test the
significance of an association between eNOS
genotype and the level of blood pressure within the entire
population except for 167 hypertensive subjects who had been under
treatment for hypertension. No significant association was observed in
either of the statistics tested. Allele frequencies of 298Asp were
concordant across the panels: 8.4% in hypertensive subjects, 8.2% in
normotensive subjects, and 7.9% and 9.5% in 2 additional sample
populations used as reference panels. Taken together, our results do
not support the previous observation that the molecular variant of the
eNOS gene may confer principal susceptibility for
essential hypertension but rather suggest the existence of
sampling variation.
Key Words: hypertension, essential Japanese genetics nitric oxide synthase
This article has been cited by other articles:
![]() |
C. X. Zhao, X. Xu, Y. Cui, P. Wang, X. Wei, S. Yang, M. L. Edin, D. C. Zeldin, and D. W. Wang Increased Endothelial Nitric-Oxide Synthase Expression Reduces Hypertension and Hyperinsulinemia in Fructose-Treated Rats J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 610 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Mitchell, C.-Y. Guo, S. Kathiresan, R. S. Vasan, M. G. Larson, J. A. Vita, M. J. Keyes, M. Vyas, C. Newton-Cheh, S. L. Musone, et al. Vascular Stiffness and Genetic Variation at the Endothelial Nitric Oxide Synthase Locus: The Framingham Heart Study Hypertension, June 1, 2007; 49(6): 1285 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gonzalez-Sanchez, M. T. Martinez-Larrad, M. E. Saez, C. Zabena, M. J. Martinez-Calatrava, and M. Serrano-Rios Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome Clin. Chem., January 1, 2007; 53(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zintzaras, G. Kitsios, and I. Stefanidis Endothelial NO Synthase Gene Polymorphisms and Hypertension: A Meta-Analysis Hypertension, October 1, 2006; 48(4): 700 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Malhotra, J. Poole, H. Davis, Y. Dong, J. Pollock, H. Snieder, and F. Treiber Effects of NOS3 Glu298Asp Polymorphism on Hemodynamic Reactivity to Stress: Influences of Ethnicity and Obesity Hypertension, December 1, 2004; 44(6): 866 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, S. R. Srinivasan, S. Li, E. Boerwinkle, and G. S. Berenson Gender-Specific Influence of NO Synthase Gene on Blood Pressure Since Childhood: The Bogalusa Heart Study Hypertension, November 1, 2004; 44(5): 668 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Schmidt, A. K Chakrabarti, C. Kehrer, D. Pfeninnger, R. D Brook, N. Kaciroti, C. Duvernoy, A. A Killeen, and S. Rajagopalan Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298->Asp) variant in determining endothelial function in coronary artery disease Vascular Medicine, August 1, 2003; 8(3): 177 - 183. [Abstract] [PDF] |
||||
![]() |
T. Kimura, T. Yokoyama, Y. Matsumura, N. Yoshiike, C. Date, M. Muramatsu, and H. Tanaka NOS3 Genotype-Dependent Correlation Between Blood Pressure and Physical Activity Hypertension, February 1, 2003; 41(2): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rankinen, T. Rice, L. Perusse, Y. C. Chagnon, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard NOS3 Glu298Asp Genotype and Blood Pressure Response to Endurance Training : The HERITAGE Family Study Hypertension, November 1, 2000; 36(5): 885 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Busse and I. Fleming A critical look at cardiovascular translational research Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1655 - H1660. [Full Text] [PDF] |
||||
![]() |
F. Soubrier Nitric Oxide Synthase Genes : Candidate Genes Among Many Others Hypertension, April 1, 1999; 33(4): 924 - 926. [Full Text] [PDF] |
||||
![]() |
T. A. Fairchild, D. Fulton, J. T. Fontana, J.-P. Gratton, T. J. McCabe, and W. C. Sessa Acidic Hydrolysis as a Mechanism for the Cleavage of the Glu298right-arrow Asp Variant of Human Endothelial Nitric-oxide Synthase J. Biol. Chem., July 6, 2001; 276(28): 26674 - 26679. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |